Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Herpes simplex virus infection downmodulates NKG2D ligand expression.

Schepis D, D'Amato M, Studahl M, Bergström T, Kärre K, Berg L.

Scand J Immunol. 2009 May;69(5):429-36. doi: 10.1111/j.1365-3083.2009.02241.x. Epub 2009 Feb 26.

2.

Varicella-Zoster Virus and Herpes Simplex Virus 1 Differentially Modulate NKG2D Ligand Expression during Productive Infection.

Campbell TM, McSharry BP, Steain M, Slobedman B, Abendroth A.

J Virol. 2015 Aug;89(15):7932-43. doi: 10.1128/JVI.00292-15. Epub 2015 May 20.

3.

Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.

Schwinn N, Vokhminova D, Sucker A, Textor S, Striegel S, Moll I, Nausch N, Tuettenberg J, Steinle A, Cerwenka A, Schadendorf D, Paschen A.

Int J Cancer. 2009 Apr 1;124(7):1594-604. doi: 10.1002/ijc.24098.

4.

Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.

Matusali G, Tchidjou HK, Pontrelli G, Bernardi S, D'Ettorre G, Vullo V, Buonomini AR, Andreoni M, Santoni A, Cerboni C, Doria M.

FASEB J. 2013 Jun;27(6):2440-50. doi: 10.1096/fj.12-223057. Epub 2013 Feb 8.

PMID:
23395909
5.

Vesicular stomatitis virus infection promotes immune evasion by preventing NKG2D-ligand surface expression.

Jensen H, Andresen L, Nielsen J, Christensen JP, Skov S.

PLoS One. 2011;6(8):e23023. doi: 10.1371/journal.pone.0023023. Epub 2011 Aug 9.

6.

NKG2D ligands expression and NKG2D-mediated cytotoxicity in human laryngeal squamous carcinoma cells.

Chen XM, Xu XQ, Sun K, Hallett WH, Zhao JD, Zhang DL.

Scand J Immunol. 2008 May;67(5):441-7. doi: 10.1111/j.1365-3083.2008.02086.x. Epub 2008 Feb 27.

7.

Heat shock protein-90 inhibitors increase MHC class I-related chain A and B ligand expression on multiple myeloma cells and their ability to trigger NK cell degranulation.

Fionda C, Soriani A, Malgarini G, Iannitto ML, Santoni A, Cippitelli M.

J Immunol. 2009 Oct 1;183(7):4385-94. doi: 10.4049/jimmunol.0901797. Epub 2009 Sep 11.

8.

Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression.

Song H, Kim J, Cosman D, Choi I.

Cell Immunol. 2006 Jan;239(1):22-30. Epub 2006 Apr 21.

PMID:
16630603
9.

NKG2D ligands expression and NKG2D-mediated NK activity in Sezary patients.

Dulphy N, Berrou J, Campillo JA, Bagot M, Bensussan A, Toubert A.

J Invest Dermatol. 2009 Feb;129(2):359-64. doi: 10.1038/jid.2008.256. Epub 2008 Aug 28.

10.

Distinct Roles for Human Cytomegalovirus Immediate Early Proteins IE1 and IE2 in the Transcriptional Regulation of MICA and PVR/CD155 Expression.

Pignoloni B, Fionda C, Dell'Oste V, Luganini A, Cippitelli M, Zingoni A, Landolfo S, Gribaudo G, Santoni A, Cerboni C.

J Immunol. 2016 Nov 15;197(10):4066-4078. Epub 2016 Oct 12.

11.

Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D.

Eleme K, Taner SB, Onfelt B, Collinson LM, McCann FE, Chalupny NJ, Cosman D, Hopkins C, Magee AI, Davis DM.

J Exp Med. 2004 Apr 5;199(7):1005-10. Epub 2004 Mar 29.

13.

Both plasmacytoid dendritic cells and monocytes stimulate natural killer cells early during human herpes simplex virus type 1 infections.

Vogel K, Thomann S, Vogel B, Schuster P, Schmidt B.

Immunology. 2014 Dec;143(4):588-600. doi: 10.1111/imm.12337.

14.

Opposing effects of interferon-alpha and interferon-gamma on the expression of major histocompatibility complex class I chain-related A in tumors.

Zhang C, Niu J, Zhang J, Wang Y, Zhou Z, Zhang J, Tian Z.

Cancer Sci. 2008 Jun;99(6):1279-86. doi: 10.1111/j.1349-7006.2008.00791.x. Epub 2008 Apr 14.

15.

Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumor cells in exosomes.

Ashiru O, Boutet P, Fernández-Messina L, Agüera-González S, Skepper JN, Valés-Gómez M, Reyburn HT.

Cancer Res. 2010 Jan 15;70(2):481-9. doi: 10.1158/0008-5472.CAN-09-1688. Epub 2010 Jan 12.

16.

Corticotropin-releasing factor induces immune escape of cervical cancer cells by downregulation of NKG2D.

Song H, Park H, Park G, Kim YS, Lee HK, Jin DH, Kang HS, Cho DH, Hur D.

Oncol Rep. 2014 Jul;32(1):425-30. doi: 10.3892/or.2014.3191. Epub 2014 May 16.

PMID:
24841552
17.

HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response.

Ward J, Davis Z, DeHart J, Zimmerman E, Bosque A, Brunetta E, Mavilio D, Planelles V, Barker E.

PLoS Pathog. 2009 Oct;5(10):e1000613. doi: 10.1371/journal.ppat.1000613. Epub 2009 Oct 2.

18.

Expression of ICP0 is sufficient to trigger natural killer cell recognition of herpes simplex virus-infected cells by natural cytotoxicity receptors.

Chisholm SE, Howard K, Gómez MV, Reyburn HT.

J Infect Dis. 2007 Apr 15;195(8):1160-8. Epub 2007 Mar 2.

PMID:
17357052
19.

Increased number and function of natural killer cells in human immunodeficiency virus 1-positive subjects co-infected with herpes simplex virus 2.

Long BR, Erickson AE, Chapman JM, Barbour JD, Vu BA, Ho EL, Lanier LL, Sauer MM, Carvalho KI, Nixon DF, Kallas EG.

Immunology. 2010 Feb;129(2):186-96. doi: 10.1111/j.1365-2567.2009.03170.x. Epub 2009 Aug 4.

20.

Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma.

Raffaghello L, Prigione I, Airoldi I, Camoriano M, Levreri I, Gambini C, Pende D, Steinle A, Ferrone S, Pistoia V.

Neoplasia. 2004 Sep-Oct;6(5):558-68.

Supplemental Content

Support Center